Trial intelligence / Profile preview

CONCERTA in Older Children with ADHD (The ABC Study)

NCT00799487Phase 4Completed

Sponsor
Janssen Pharmaceutical
Start
Jan 2009
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of methylphenidate-OROS in attention deficit hyperactivity disorder (ADHD), sponsored by Janssen Pharmaceutical. Started Jan 2009; status: completed.

02

Drugs

methylphenidate-OROS
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT00799487.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00799487.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call